No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
UAE – State-owned Dubai Academic Health Corporation (DAHC), AXDEV Group, and Pfizer have signed a public-private partnership for improving chronic disease management. It follows the emerging trends of world-class healthcare…
Read More
USA — Pfizer has issued a recall for 4.2 million packages of Nurtec ODT, which is used to treat migraines in adults. The U.S. Consumer Product Safety Commission (CPSC) raised…
Read More
USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of severe disease…
Read More
SOUTH AFRICA – Pfizer and Biovac have launched a freezer farm facility which will serve as an ultracold storage facility and add to the institute’s capacity for vaccine storage and…
Read More
USA — The U.S. Food and Drug Administration (FDA) has approved Pfizer’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. As the first…
Read More
USA —Pfizer has agreed to acquire Seagen, a Seattle-based biotechnology company that develops novel tumor-killing medicine, for US$43 billion in one of the biggest deals in the biotech industry in…
Read More
USA —According to recent reports by Reuters, Pfizer, a US-based pharmaceutical company, has developed a vaccine for respiratory syncytial virus (RSV) and is prepared to launch it pending regulatory approval.…
Read More
SOUTH KOREA — Samsung Biologics, a contract development and manufacturing organization (CDMO), has signed a biologics supply contract with pharma giant Pfizer worth KRW 241 billion (US$183 million) and it…
Read More
USA — Pfizer and Valneva are dropping roughly half of the 7,000 total participants enrolled in the Phase III trial of the experimental Lyme disease vaccine VLA15 in the U.S.…
Read More
BELGIUM — Pfizer representatives will maintain their access to the European Parliament, despite facing possible expulsion amidst the ongoing controversy surrounding the purchase of COVID-19 vaccines. According to EurActiv, the…
Read More